• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: Drug Overdose Deaths; New Anthem CEO; Diabetes Technology


CDC released a report showing a more than 17% increase in drug overdose deaths last year; Gail K. Boudreaux will step in as new Anthem CEO; and the first glucose-monitoring system that doesn’t require a blood sample will hopefully be introduced by the end of 2018.

Sharp Increase in Drug Overdose Deaths Last Year

Joseph Swedish Out, Gail Boudreaux in as Anthem CEO

High-Tech Relief for People with Diabetes

Drug overdoses have become the leading cause of death for Americans under 50. On Friday, CDC released a report that showed deaths by drug overdose increased by more than 17% last year. Preliminary data from the fourth quarter of 2015 to the fourth quarter of 2016 show that the rate of fatal overdoses rose to approximately 20 people per 100,000, up from 16.6 per 100,000, according to The New York Times. The highest rates reported were from New Hampshire, Kentucky, West Virginia, Ohio, and Rhode Island.Anthem has chosen a former top executive from one of its biggest competitors to replace Joseph Swedish as its next CEO, according to The Associated Press. Gail K. Boudreaux will start November 20. Swedish will continue to serve as executive chairman until May, and will then will serve as senior advisor for a couple more years. Anthem did not cite a reason for the departure of Swedish, who has been CEO for more than 4 years. Boudreaux served as CEO of UnitedHealthcare until November 2014.The days of routine finger pricking and imprecise glucose meters may soon be over, according to Bloomberg. Manufacturers have begun to incorporate the consumer-friendly designs of Silicon Valley, linking to smart phones and other devices. In September, regulators approved the first glucose-monitoring system that doesn’t require a blood sample. The FreeStyle Libre utilizes a sensor that is worn on the back of the arm. Last Wednesday, executives said the company hopes to introduce the device by the end of 2018.

Related Videos
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Stephen Nicholls, MD, Monash University and Victorian Heart Hospital
Amal Agarwal, DO, MBA
Dr Robert Groves
Dr Robert Groves
Jeremy Wigginton, MD
Related Content
© 2023 MJH Life Sciences
All rights reserved.